iota Biosciences, Inc. powered by Astellas

iota Biosciences, Inc., a subsidiary of Astellas Pharma US, is a medical device company focused on developing bioelectronics for diagnostic and therapeutic applications. Founded in 2017 as a spinout from the University of California, Berkeley, the company is based in Alameda, California, and employs around 95-99 people. iota specializes in advancing brain-machine interfaces and implantable devices aimed at treating chronic conditions such as spinal cord injuries, strokes, and bladder disorders. The company utilizes proprietary ultrasonic technology to create small, implantable bioelectronic devices that offer innovative clinical solutions beyond traditional pharmaceuticals. iota's mission is to enhance patient care through state-of-the-art bioelectronics. Their work has progressed from initial concepts to functional prototypes, with a strong emphasis on quality and agility, supported by their partnership with Astellas Pharma. This collaboration enhances iota's capabilities in research and development, aiming to address significant unmet medical needs.